Pharmacokinetics of EFV 400mg Once Daily During Pregnancy in HIV+ Women
Phase of Trial: Phase I
Latest Information Update: 24 Oct 2017
At a glance
- Drugs Efavirenz (Primary) ; Emtricitabine/tenofovir; Lamivudine; Lamivudine/zidovudine; Tenofovir
- Indications HIV-1 infections
- Focus Pharmacokinetics
- 19 Oct 2017 Status changed from active, no longer recruiting to completed.
- 21 Jul 2017 Planned End Date changed from 1 Sep 2017 to 1 Dec 2017.
- 21 Jul 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Oct 2017.